UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | G | J | K | L | M | O | P | R | S | T | W
Number of items: 62.

A

Aligianis, IA; Forshew, T; Johnson, S; Michaelides, M; Johnson, CA; Trembath, RC; ... Maher, ER; + view all (2002) Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J MED GENET , 39 (9) 656 - 660.

Attygalle, A; Al-Jehani, R; Diss, TC; Munson, P; Liu, HX; Du, MQ; ... Dogan, A; + view all (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. BLOOD , 99 (2) 627 - 633. 10.1182/blood.V99.2.627.

B

Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; ... Albanell, J; + view all (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Belorgey, D; Crowther, DC; Mahadeva, R; Lomas, DA; (2002) Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem , 277 (19) 17367 - 17373. 10.1074/jbc.M200680200. Gold open access

Biganzoli, L; Cufer, T; Bruning, P; Coleman, R; Duchateau, L; Calvert, AH; ... Piccart, MJ; + view all (2002) Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. J CLIN ONCOL , 20 (14) 3114 - 3121. 10.1200/JCO.2002.11.005.

Boshoff, C; Weiss, R; (2002) Aids-related malignancies. NAT REV CANCER , 2 (5) 373 - 382. 10.1038/nrc797.

Byrne, E; (2002) Autoimmune myasthenia gravis: place of thymectomy and preferredtechnique. Internal Medicine Journal , 32 (8) 365 - 366.

Byrne, E; (2002) Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? Journal of Clinical Neuroscience , 9 (5) 497 - 501.

C

Carrell, RW; Lomas, DA; (2002) Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med , 346 (1) 45 - 53. 10.1056/NEJMra010772.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; ... Milligan, DW; + view all (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; ... Milligan, DW; + view all (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Crotaz, GR; Solanki, C; Ballinger, JR; Parmar, JS; Lomas, DA; Chilvers, ER; (2002) A novel method of radiolabelling alpha(1)-antitrypsin monomer and polymers. JOURNAL OF NUCLEAR MEDICINE , 43 (5) , Article UNSP 200192.

D

Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; ... Futreal, PA; + view all (2002) Mutations of the BRAF gene in human cancer. Nature , 417 (6892) 949 - 954. 10.1038/nature00766.

Davies, JK; Koh, MB; Prentice, HG; Lowdell, MW; (2002) Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. BONE MARROW TRANSPL , 29 S45 - S46.

Davis, RL; Shrimpton, AE; Carrell, RW; Lomas, DA; Gerhard, L; Baumann, B; ... Holohan, PD; + view all (2002) Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet , 359 (9325) 2242 - 2247. 10.1016/S0140-6736(02)09293-0.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; ... Madrigal, JA; + view all (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 66 - 66.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

E

Ezoe, S; Matsumura, I; Nakata, S; Gale, K; Ishihara, K; Minegishi, N; ... Kanakura, Y; + view all (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. BLOOD , 100 (10) 3512 - 3520.

G

Going, JJ; Keith, WN; Neilson, L; Stoeber, K; Stuart, RC; Williams, GH; (2002) Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. GUT , 50 (3) 373 - 377. Green open access
file

Goldring, K; Jones, GE; Poirier, F; Prasad, R; Tavsanoglu, Y; Watt, DJ; (2002) The galectin-1 null mouse furthers the understanding of the role of galectin-1 in muscle formation, differentiation and regeneration. In: NEUROMUSCULAR DISORDERS. (pp. 719 - 720). PERGAMON-ELSEVIER SCIENCE LTD

Goldring, K; Jones, GE; Sewry, CA; Watt, DJ; (2002) The muscle-specific marker desmin is expressed in a proportion of human dermal fibroblasts after their exposure to galectin-1. NEUROMUSCULAR DISORD , 12 (2) 183 - 186.

Goldring, K; Jones, GE; Thiagarajah, R; Watt, DJ; (2002) The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J CELL SCI , 115 (2) 355 - 366.

Goldring, K; Partridge, T; Watt, D; (2002) Muscle stem cells. J PATHOL , 197 (4) 457 - 467. 10.1002/path.1157.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; ... Solomon, E; + view all (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

J

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; ... Wickremasinghe, RG; + view all (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access
file

K

Kapsa, RM; Quigley, AF; Vadolas, J; Steeper, K; Ioannou, PA; Byrne, E; Kornberg, AJ; (2002) Targeted gene correction in the mdX mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Therapy , 9 (11) 695 - 699.

Kapsa, RMI; Wong, SHA; Bertoncello, I; Quigley, AF; Williams, B; Sells, K; ... Kornberg, AJ; + view all (2002) CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci. Neuromuscular Disorders , 12 S61 - S66.

Koch, SSC; Thoresen, LH; Tikhe, JG; Maegley, KA; Almassy, RJ; Li, JK; ... Hostomsky, Z; + view all (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J MED CHEM , 45 (23) 4961 - 4974. 10.1021/jm02059n.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

L

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Lomas, DA; (2002) Chronic obstructive pulmonary disease. Introduction. Thorax , 57 (8) 735 - ?.

Lomas, DA; Carrell, RW; (2002) Serpinopathies and the conformational dementias. Nat Rev Genet , 3 (10) 759 - 768. 10.1038/nrg907.

Lomas, DA; Lourbakos, A; Cumming, SA; Belorgey, D; (2002) Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia. Biochem Soc Trans , 30 (2) 89 - 92.

Lomas, DA; Mahadeva, R; (2002) alpha(1)-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. JOURNAL OF CLINICAL INVESTIGATION , 110 (11) 1585 - 1590. 10.1172/JCI200216782.

Lomas, DA; Mahadeva, R; (2002) Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest , 110 (11) 1585 - 1590. 10.1172/JCI16782.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.

M

Mackie, IJ; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; ... Rumley, A; + view all (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. THROMB HAEMOSTASIS , 87 (6) 997 - 1005.

Mahadeva, R; Dafforn, TR; Carrell, RW; Lomas, DA; (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem , 277 (9) 6771 - 6774. 10.1074/jbc.C100722200. Gold open access

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; McArdle, C; Seymour, MT; ... British MRC Colorectal Canc Work,; + view all (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. LANCET , 359 (9317) 1555 - 1563.

McKelvie, PA; Collins, S; Thyagarajan, D; Trost, N; Sheorey, H; Byrne, E; (2002) Meningoencephalomyelitis with vasculitis due to varicella zoster virus : a case report and review of the literature. Pathology , 34 (1) 88 - 93.

O

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; ... Meignin, V; + view all (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) 2331 - 2336.

P

Parmar, JS; Mahadeva, R; Reed, BJ; Farahi, N; Cadwallader, KA; Keogan, MT; ... Lomas, DA; + view all (2002) Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol , 26 (6) 723 - 730. 10.1165/ajrcmb.26.6.4739.

Patel, BD; Tasker, A; Screaton, N; Anderson, W; Sharma, S; Silverman, EK; Lomas, DA; (2002) Smoking related emphysema and small airways disease have independent genetic risk factors in COPD. In: THORAX.

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; ... Spanish United Kingdom Collaborat,; + view all (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Peters, GJ; Backus, HHJ; Freemantle, S; van Triest, B; Codacci-Pisanelli, G; van der Wilt, CL; ... Pinedo, HM; + view all (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1587 (2-3) 194 - 205.

Pileri, SA; Grogan, TM; Harris, NL; Banks, P; Campo, E; Chan, JKC; ... Weiss, LM; + view all (2002) Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology , 41 (1) 1 - 29. 10.1046/j.1365-2559.2002.01418.x.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol , 76 (10) 5051 - 5061.

R

Radosavljevic, M; Cuillerier, B; Wilson, MJ; Clement, O; Wicker, S; Gilfillan, S; ... Bahram, S; + view all (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. GENOMICS , 79 (1) 114 - 123. 10.1006/geno.2001.6673.

S

Salomoni, P; Pandolfi, PP; (2002) The role of PML in tumor suppression. CELL , 108 (2) 165 - 170.

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; ... Hartley, JA; + view all (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access
file

Sugie, K; Yamamoto, A; Murayama, K; Nonaka, I; Nishino, I; Oh, SJ; ... Hirano, M; + view all (2002) Clinicopathological features of genetically-confirmed Danon disease. Journal of the Neurological Sciences , 199 S105 - S105.

Sugie, K; Yamamoto, A; Murayama, K; Takahashi, M; Mora, M; Riggs, JE; ... Nishino, I; + view all (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology , 58 (12) 1773 - 1778.

T

Thyagarajan, D; Byrne, E; (2002) Mitochondrial disorders of the nervous system: Clinical, biochemical, and molecular genetic features. Mitochondrial Function and Dysfunction , 53 93 - 144.

Tipping, AJ; Mahon, FX; Zafirides, G; Lagarde, V; Goldman, JM; Melo, JV; (2002) Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. LEUKEMIA , 16 (12) 2349 - 2357. 10.1038/sj.leu.2402775.

W

Ward, KN; White, RP; Mackinnon, S; Hanna, M; (2002) Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. BONE MARROW TRANSPL , 30 (12) 983 - 985. 10.1038/sj.bmt.1703774.

Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; ... Mouse Genome Sequencing Consor,; + view all (2002) Initial sequencing and comparative analysis of the mouse genome. NATURE , 420 (6915) 520 - 562. 10.1038/nature01262.

Watt, DJ; Jones, GE; Goldring, K; (2002) The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration. GLYCOCONJUGATE J , 19 (7-9) 615 - 619.

This list was generated on Sun Nov 23 03:30:50 2014 GMT.